What is the recommended adult immunization schedule for a 23‑year‑old man with newly diagnosed ulcerative colitis and no reliable vaccine record?

Recommended Immunization Schedule for a 23-Year-Old Man with Newly Diagnosed Ulcerative Colitis and No Reliable Vaccine Record

This patient should receive a comprehensive catch-up immunization series including influenza, pneumococcal (PCV20 or PCV15 followed by PPSV23), hepatitis B, Tdap, HPV, recombinant herpes zoster, and meningococcal vaccines, ideally administered before starting any immunosuppressive therapy. 1, 2

Priority: Vaccinate Before Immunosuppression

The most critical timing consideration is administering vaccines before initiating immunosuppressive therapy whenever possible, as vaccine efficacy may be reduced once immunosuppression begins. However, vaccination should never delay necessary IBD treatment 1, 2. If immunosuppression must start immediately, inactivated vaccines remain safe and should still be given, though response may be suboptimal.

Core Vaccine Schedule for This 23-Year-Old Patient

Strongly Recommended (High Priority)

Influenza vaccine - Annual administration strongly recommended for all adult IBD patients 3. Use standard-dose inactivated vaccine for patients under 65 years 2.

Pneumococcal vaccination - Critical for IBD patients due to increased risk of invasive pneumococcal disease 3. For this patient:

• PCV20 as single dose (preferred option) 4, 2, OR
• PCV15 followed by PPSV23 at least 8 weeks later if immunocompromised, or 1 year later if not 2
• If starting immunosuppressive therapy, pneumococcal vaccines are conditionally recommended 3
• Booster with PPSV23 at 5 years if on long-term immunosuppression 1

Hepatitis B vaccine - Strongly recommended for unimmunized adults with IBD, particularly those with risk factors, but suggested even without specific risk factors 3. Options include:

• HEPLISAV-B: 2-dose series at 0 and 1 month (preferred for simplicity) 2
• ENGERIX-B or Recombivax HB: 3-dose series at 0,1, and 6 months 2
• Check anti-HBs titers post-vaccination to confirm response 1

Tdap/Td - Strongly recommended for all adult IBD patients 3. Ensure at least one dose of Tdap, then Td boosters every 10 years 2.

Conditionally Recommended (Moderate Priority)

Recombinant herpes zoster vaccine (Shingrix) - Conditionally recommended for adults under 50 years with IBD 3. Given this patient's age (23), consider administration especially if immunosuppressive therapy is planned:

• 2-dose series: 4-8 weeks apart if on immunosuppressive therapy, or 8-12 weeks apart if not 2
• Becomes strongly recommended if patient will start JAK inhibitors 1

HPV vaccine (Gardasil 9) - Strongly recommended for patients aged 9-26 years 3. This 23-year-old male should receive:

• 3-dose series at 0,1-2, and 6 months 2
• Male patients in this age group have conditional recommendation (very low evidence), but vaccination is still advised 3

Haemophilus influenzae type b (Hib) - Conditionally recommended for unimmunized adults with IBD 3. Evidence shows increased risk of Hib pneumonia in IBD patients (aOR 1.34) 3.

Meningococcal vaccines - Strongly recommended only if specific risk factors for invasive meningococcal disease are present 3. Without documented risk factors, no recommendation can be made 3.

Critical Timing Considerations

If Patient Is NOT Yet on Immunosuppression:

• Administer all inactivated vaccines immediately
• Wait 4 weeks after any live vaccines before starting immunosuppressive therapy 1
• Live vaccines (MMR, varicella) can be considered if patient lacks immunity and there's a 4-week window before immunosuppression 1

If Patient Will Start Immunosuppression:

• Prioritize pneumococcal, influenza, and hepatitis B vaccines
• Avoid live vaccines once immunosuppression begins
• Live vaccines contraindicated with: corticosteroids ≥20 mg/day for ≥2 weeks, purine analogues, methotrexate, biologics, JAK inhibitors 1

If Patient Is Already on Immunosuppression:

• All inactivated vaccines remain safe and should be given 2
• Administer vaccines when corticosteroid dose is lowest possible 2
• Live vaccines absolutely contraindicated until 3 months after stopping immunosuppression 1

Special Considerations

Varicella immunity: Check history of chickenpox or obtain varicella serology. If non-immune and not yet on immunosuppression, live varicella vaccine can be given with appropriate timing 1. If already immunosuppressed, counsel on post-exposure prophylaxis with aciclovir if exposed 1.

MMR immunity: If uncertain immunity and not on immunosuppression, give 2-dose series at least 4 weeks apart 2. Do not delay for serology if vaccination history is unclear 2.

Documentation: Establish comprehensive vaccine record going forward, as this patient has no reliable history 2.

Common Pitfalls to Avoid

• Do not delay IBD treatment to complete vaccination series—start treatment when medically necessary 1, 2
• Do not give live vaccines to patients on biologics, JAK inhibitors, high-dose corticosteroids, or other immunosuppressives 1
• Do not assume vaccines will cause IBD flares—inactivated vaccines are safe and do not exacerbate disease activity 2
• Do not forget annual influenza vaccination—this is a lifelong requirement for IBD patients 3, 2
• Do not skip hepatitis B serology post-vaccination—confirm protective antibody response 1